| 000 | 01121 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513223344.0 | ||
| 264 | 0 | _c20001207 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a1091-5362 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBostwick, D G | |
| 245 | 0 | 0 |
_aImmunohistochemical changes in prostate cancer after androgen deprivation therapy. _h[electronic resource] |
| 260 |
_bMolecular urology _c2000 |
||
| 300 |
_a101-6;discussion 107 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAndrogens _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstate _xmetabolism |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Androgen _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tMolecular urology _gvol. 4 _gno. 3 _gp. 101-6;discussion 107 |
|
| 999 |
_c11004887 _d11004887 |
||